United Therapeutics (UTHR)

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

{% set status = marketHours.currentMarketStatus if marketHours.currentMarketStatus == "pre-market" or marketHours.currentMarketStatus == "after-hours" %}{% set hasHighAndLow = tickerData.data[dynamicVariables.equity upper].high and tickerData.data[dynamicVariables.equity upper].low %}{% if resolvedDynamicVariables[dynamicVariables.equity].subclass == "stock" %} () 股票 今日價格為 ，自市場 {% if status %} 上次收盤 {% else %} 開盤以來錄得 變動。該公司的市值為 ，日交易量為 股。{% if hasHighAndLow %}對於關注價格走勢的投資者而言， 股票今日的波動區間介於 和 之間。{% endif %} 上一個收盤價為 。{% else %} () ETF 今日價格為 。  ETF 當前 {% if resolvedDynamicVariables[dynamicVariables.equity].market_cap %} 市值為 ，{% endif %} 日交易量為 股。

{% if hasHighAndLow %}對於分析 ETF 表現的投資者而言， 當天的波動區間在 和 之間，前一交易日收盤價為 。透過這些資料可以深入了解近期的價格波動和流動性。{% endif %}

{% endif %}

是否準備好開始交易？請按照以下步驟操作，或閱讀我們的指南 如何在 Kraken 上購買 United Therapeutics 股票，起始金額為 $10。